The elevated expression of IQGAP1, particularly in conjunction with pY105-PKM2, underscores their importance in NSCLC pathogenesis and positions them as promising therapeutic targets to mitigate stemness and malignant progression. The gene discussed is PKM; the disease is non-small cell lung carcinoma.